Literature DB >> 361893

Demonstration of the in vitro phagocytosis of Treponema pallidum by rabbit peritoneal macrophages.

S A Lukehart, J N Miller.   

Abstract

Evidence has been provided for the in vitro phagocytosis of virulent Treponema pallidum by stimulant-induced peritoneal macrophages. After the 4-hr incubation of macrophages with T. pallidum, treponemal antigens associated with the macrophages are specifically stained using indirect immunofluorescent techniques. Phagocytized treponemes appear within the cytoplasm of macrophages as round, brightly fluorescent "bodies" observable in increasing numbers as the duration of the treponeme-phagocyte interaction increases. Their presence is significantly reduced in the cytoplasm of macrophages that have been treated with cytochalasin B, a known inhibitor of phagocytosis, and in nonphagocytic fibroblasts. Additionally, supportive evidence for T. pallidum phagocytosis in vitro has been provided by electron microscopic examination in which treponemes have been demonstrated within typical phagocytic vacuoles. This study also provides evidence that immune serum factor(s) significantly promote the phagocytosis of T. pallidum, although a contribution by heat-labile serum factors has not been demonstrated. The possible mechanisms of immune serum contribution and the implications of the demonstration of T. pallidum phagocytosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361893

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  Membrane topology and cellular location of the Treponema pallidum glycerophosphodiester phosphodiesterase (GlpQ) ortholog.

Authors:  D V Shevchenko; T J Sellati; D L Cox; O V Shevchenko; E J Robinson; J D Radolf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Protection against syphilis correlates with specificity of antibodies to the variable regions of Treponema pallidum repeat protein K.

Authors:  Cecilia A Morgan; Sheila A Lukehart; Wesley C Van Voorhis
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum.

Authors:  Brandon T Leader; Karin Hevner; Barbara J Molini; Lynn K Barrett; Wesley C Van Voorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 4.  Syphilis: using modern approaches to understand an old disease.

Authors:  Emily L Ho; Sheila A Lukehart
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

5.  Contribution of rabbit leukocyte defensins to the host response in experimental syphilis.

Authors:  L A Borenstein; T Ganz; S Sell; R I Lehrer; J N Miller
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

6.  Entry of Borrelia burgdorferi into macrophages is end-on and leads to degradation in lysosomes.

Authors:  R R Montgomery; S E Malawista
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

7.  Ability of macrophages to process and present Treponema pallidum Bosnia A strain antigens in experimental syphilis of syrian hamsters.

Authors:  O Bagasra; I Damjanov
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  Activation of macrophages by products of lymphocytes from normal and syphilitic rabbits.

Authors:  S A Lukehart
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Murine monoclonal antibodies specific for virulent Treponema pallidum (Nichols).

Authors:  S M Robertson; J R Kettman; J N Miller; M V Norgard
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

10.  Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase.

Authors:  C E Cameron; C Castro; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.